NCT00602550View on ClinicalTrials.gov

Bioequivalency Study of Zidovudine Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions
HIV Infections
Interventions
DRUG

Zidovudine

Trial Locations (1)

78759

CEDRA Clinical Research, Austin

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00602550 - Bioequivalency Study of Zidovudine Under Fasting Conditions | Biotech Hunter | Biotech Hunter